PIM
TRIB

Paradice Investment Management’s Trinity Biotech TRIB Stock Holding History

Paradice Investment Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-10,287
Closed -$1.7M – 47
2020
Q1 		$1.7M Hold
10,287
– – 0.17% 38
2019
Q4 		$1.59M Hold
10,287
– – 0.11% 40
2019
Q3 		$1.87M Hold
10,287
– – 0.14% 41
2019
Q2 		$2.85M Sell
10,287
-272
-3% -$97K 0.22% 31
2019
Q1 		$4.51M Hold
10,559
– – 0.34% 31
2018
Q4 		$3.63M Sell
10,559
-370
-3% -$171K 0.31% 33
2018
Q3 		$6.56M Hold
10,929
– – 0.45% 33
2018
Q2 		$8.2M Hold
10,929
– – 0.55% 31
2018
Q1 		$8.44M Hold
10,929
– – 0.61% 29
2017
Q4 		$8.36M Hold
10,929
– – 0.61% 31
2017
Q3 		$9.2M Hold
10,929
– – 0.69% 30
2017
Q2 		$9.84M Buy
10,929
+86
+0.8% +$73.1K 0.78% 28
2017
Q1 		$9.69M Hold
10,843
– – 0.81% 29
2016
Q4 		$11.3M Hold
10,843
– – 1.07% 26
2016
Q3 		$21.5M Hold
10,843
– – 2.44% 21
2016
Q2 		$18.4M Buy
10,843
+1,272
+13% +$2.15M 2.21% 22
2016
Q1 		$16.7M Buy
9,571
+415
+5% +$661K 2.23% 19
2015
Q4 		$16.2M Buy
9,156
+2,541
+38% +$4.5M 2.31% 18
2015
Q3 		$11.4M Buy
6,615
+1,242
+23% +$3M 2.07% 22
2015
Q2 		$14.6M Buy
5,373
+1,480
+38% +$3.84M 2.44% 18
2015
Q1 		$11.2M Buy
3,893
+266
+7% +$738K 2.36% 19
2014
Q4 		$9.51M Buy
3,627
+1,302
+56% +$3.37M 2.06% 20
2014
Q3 		$6.37M Buy
2,325
+731
+46% +$2.37M 1.66% 21
2014
Q2 		$5.51M Buy
1,594
+46
+3% +$164K 1.64% 23
2014
Q1 		$5.63M Sell
1,548
-49
-3% -$193K 1.8% 24
2013
Q4 		$6.01M Buy
+1,597
New +$5.75M 1.94% 25

Other funds holding TRIB

SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

Paradice Investment Management's TRIB Position: Q2 2020 in Review

Paradice Investment Management sold out of Trinity Biotech (TRIB) in Q2 2020, closing a stake of 10,287 shares — an estimated $1.7M sold.

Paradice Investment Management first reported a position in TRIB in Q4 2013 and held it in 26 quarters. The position peaked at $21.5M in Q3 2016. 26 funds tracked by Wall St. Rank hold TRIB as of Q2 2020.

  • Paradice Investment Management reported no remaining Trinity Biotech position as of Q2 2020 after selling out during the quarter.
  • Paradice Investment Management sold 10,287 Trinity Biotech shares in Q2 2020, an estimated $1.7M.
  • Paradice Investment Management first reported a position in Trinity Biotech in Q4 2013 and held it in 26 quarters.
  • Paradice Investment Management's Trinity Biotech position peaked at $21.5M in Q3 2016.
  • 26 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2020.

Based on Paradice Investment Management's 13F filing for Q2 2020, filed 6 Aug 2020.